Isolation and transplantation of highly purified autologous and allogeneic CD34+ progenitors.

被引：0
|
作者：
Handgretinger, R [1 ]
Lang, P [1 ]
Kuci, S [1 ]
Schlegel, PG [1 ]
Niethammer, D [1 ]
Klingebiel, T [1 ]
机构：
[1] UNIV TUBINGEN,CHILDRENS HOSP,TUBINGEN,GERMANY
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1000 / 1000
页数：1
相关论文
共 50 条
  • [21] Experience with CD34+ positive selection for autologous and allogeneic transplantation using the CliniMACS device.
    Schumm, M
    Lang, P
    Kuci, S
    Klingebiel, T
    Bühring, HJ
    Niethammer, D
    Handgretinger, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S209 - S209
  • [22] Development of engineered hematopoietic growth factors for multilineage expansion and maturation of CD34+ progenitors.
    Kahn, LE
    Staten, NR
    Wood, DC
    Favara, JP
    Pegg, LE
    Thomas, JW
    Burnette, BL
    Huynh, MS
    Baum, CM
    McKearn, JP
    Giri, GD
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 258 - 258
  • [23] Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors
    Bomberger, C
    Singh-Jairam, M
    Rodey, G
    Guerriero, A
    Yeager, AM
    Fleming, WH
    Holland, HK
    Waller, EK
    BLOOD, 1998, 91 (07) : 2588 - 2600
  • [24] Donor lymphocyte infusions after transplantation of allogeneic, highly purified peripheral blood CD34+ cells in chronic myelogenous leukemia.
    Peceny, R
    Elmaagacli, AH
    Trenschel, R
    Ottinger, H
    Beelen, DW
    BLOOD, 2003, 102 (11) : 423B - 423B
  • [25] Allogeneic transplantation of purified CD34+ cells from peripheral blood:: Spanish experience of 62 cases
    Urbano-Ispizua, A
    Solano, C
    Brunet, S
    de la Rubia, J
    Odriozola, J
    Zuazu, J
    Figuera, A
    Caballero, D
    Martínez, C
    García, J
    Sanz, G
    Torrabadella, M
    Alegre, A
    Pérez-Oteiza, J
    Jurado, M
    Oyonarte, S
    Sierra, J
    García-Conde, J
    Rozman, C
    BONE MARROW TRANSPLANTATION, 1998, 21 : S71 - S74
  • [26] Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia
    Lang, P
    Handgretinger, R
    Niethammer, D
    Schlegel, PG
    Schumm, M
    Greil, J
    Bader, P
    Engel, C
    Scheel-Walter, H
    Eyrich, M
    Klingebiel, T
    BLOOD, 2003, 101 (04) : 1630 - 1636
  • [27] A proteomic characterization of early-stage erythropoietic differenciation in human hematopoietic (CD34+) progenitors.
    Chen, SC
    Su, BS
    Wu, CY
    Huang, CT
    Shih, DT
    BLOOD, 2002, 100 (11) : 226A - 226A
  • [28] Effects of cytokine combination on retroviral gene transduction into CD34+ peripheral blood myeloid progenitors.
    Kim, HJ
    Okamoto, Y
    Kawano, Y
    Ito, M
    Takaue, Y
    Shimada, T
    Kuroda, Y
    BLOOD, 1996, 88 (10) : 3894 - 3894
  • [29] Molecular mechanism of TGFβ-mediated cell cycle modulation in primary human CD34+ progenitors.
    Dao, MA
    Hwa, J
    Nolta, JA
    BLOOD, 2001, 98 (11) : 81A - 81A
  • [30] The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors.
    Araki, H
    Katayama, N
    Masuya, M
    Hoshino, N
    Miyashita, H
    Sakano, S
    Yamaguchi, M
    Nishii, K
    Minami, N
    Shiku, H
    BLOOD, 2001, 98 (11) : 74A - 74A
12345